Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamath, K.
Right arrow Articles by Jordan, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamath, K.
Right arrow Articles by Jordan, M. A.
[Cancer Research 63, 6026-6031, September 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Suppression of Microtubule Dynamics by Epothilone B Is Associated with Mitotic Arrest1

Kathy Kamath2 and Mary Ann Jordan

Department of Molecular Cellular and Developmental Biology and the Neuroscience Research Institute, University of California, Santa Barbara, California, 93106

The epothilones are a group of novel microtubule-targeted, antimitotic compounds that have a paclitaxel-like, assembly enhancing effect on tubulin in vitro as well as in cultured cells. We hypothesize that epothilones induce mitotic arrest by suppressing microtubule dynamics. To test this hypothesis, we used MCF7 cells stably transfected with GFP-{alpha}-tubulin to analyze microtubule dynamics at three concentrations of epothilone B, one that induced no mitotic arrest (0.2 nM, 20 h), one that induced one-third maximal mitotic arrest (IC33, 2 nM, 20 h), and one that induced half-maximal mitotic arrest (IC50, 3.5 nM, 20 h). We found that epothilone B suppressed microtubule dynamics in a concentration-dependent manner coincident with mitotic block. At 0.2 nM epothilone B, dynamics were not significantly altered. At 2 nM epothilone B (IC33), the mean growth and shortening rates were decreased by 38 and 27%, respectively. Dynamicity was decreased by 47%. At the IC50, 80% of the cells had nearly complete stabilization of microtubule dynamics, and no anaphase or telophase figures were observed. Comparison of the effects of epothilone B on microtubule dynamics with those of paclitaxel indicated that both drugs alter the same microtubule dynamic parameters to a similar extent. At the IC50 for mitotic arrest, dynamicity was reduced by 54% by paclitaxel compared with 62% for epothilone B. In 65% of the cells treated with paclitaxel, the microtubules were completely stabilized. Thus, the effects of epothilone B on microtubule dynamics are remarkably similar to those of paclitaxel, suggesting that both drugs induce mitotic block by a similar mechanism.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
E. A. Perez
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
Mol. Cancer Ther., August 1, 2009; 8(8): 2086 - 2095.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. E. Bekier, R. Fischbach, J. Lee, and W. R. Taylor
Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit
Mol. Cancer Ther., June 1, 2009; 8(6): 1646 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhou, C. C. Vos, A. Gjyrezi, M. Yoshida, F. R. Khuri, F. Tamanoi, and P. Giannakakou
The Protein Farnesyltransferase Regulates HDAC6 Activity in a Microtubule-dependent Manner
J. Biol. Chem., April 10, 2009; 284(15): 9648 - 9655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. T. T. Bach, S. Creed, J. Zhong, M. Mahmassani, G. Schevzov, J. Stehn, L. N. Cowell, P. Naumanen, P. Lappalainen, P. W. Gunning, et al.
Tropomyosin Isoform Expression Regulates the Transition of Adhesions To Determine Cell Speed and Direction
Mol. Cell. Biol., March 15, 2009; 29(6): 1506 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Dumontet, M. A. Jordan, and F. F.Y. Lee
Ixabepilone: targeting {beta}III-tubulin expression in taxane-resistant malignancies
Mol. Cancer Ther., January 1, 2009; 8(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. Azarenko, T. Okouneva, K. W. Singletary, M. A. Jordan, and L. Wilson
Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane
Carcinogenesis, December 1, 2008; 29(12): 2360 - 2368.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Mohan and D. Panda
Kinetic Stabilization of Microtubule Dynamics by Estramustine Is Associated with Tubulin Acetylation, Spindle Abnormalities, and Mitotic Arrest
Cancer Res., August 1, 2008; 68(15): 6181 - 6189.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Okouneva, O. Azarenko, L. Wilson, B. A. Littlefield, and M. A. Jordan
Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase
Mol. Cancer Ther., July 1, 2008; 7(7): 2003 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. J. Lee and S. M. Swain
The Epothilones: Translating from the Laboratory to the Clinic
Clin. Cancer Res., March 15, 2008; 14(6): 1618 - 1624.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ray, T. Okouneva, T. Manna, H. P. Miller, S. Schmid, L. Arthaud, R. Luduena, M. A. Jordan, and L. Wilson
Mechanism of Action of the Microtubule-Targeted Antimitotic Depsipeptide Tasidotin (Formerly ILX651) and Its Major Metabolite Tasidotin C-Carboxylate
Cancer Res., April 15, 2007; 67(8): 3767 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Failly, S. Korur, V. Egler, J.-L. Boulay, M. M. Lino, R. Imber, and A. Merlo
Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells
Mol. Cancer Ther., February 1, 2007; 6(2): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Kamath, T. Okouneva, G. Larson, D. Panda, L. Wilson, and M. A. Jordan
2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
Mol. Cancer Ther., September 1, 2006; 5(9): 2225 - 2233.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. A. Jordan, K. Kamath, T. Manna, T. Okouneva, H. P. Miller, C. Davis, B. A. Littlefield, and L. Wilson
The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth
Mol. Cancer Ther., July 1, 2005; 4(7): 1086 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. I. Marcus, J. Zhou, A. O'Brate, E. Hamel, J. Wong, M. Nivens, A. El-Naggar, T.-P. Yao, F. R. Khuri, and P. Giannakakou
The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase
Cancer Res., May 1, 2005; 65(9): 3883 - 3893.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kamath, L. Wilson, F. Cabral, and M. A. Jordan
{beta}III-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability
J. Biol. Chem., April 1, 2005; 280(13): 12902 - 12907.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Pasquier, S. Honore, B. Pourroy, M. A. Jordan, M. Lehmann, C. Briand, and D. Braguer
Antiangiogenic Concentrations of Paclitaxel Induce an Increase in Microtubule Dynamics in Endothelial Cells but Not in Cancer Cells
Cancer Res., March 15, 2005; 65(6): 2433 - 2440.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Lin, L. Catley, R. LeBlanc, C. Mitsiades, R. Burger, Y.-T. Tai, K. Podar, M. Wartmann, D. Chauhan, J. D. Griffin, et al.
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo
Blood, January 1, 2005; 105(1): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Honore, K. Kamath, D. Braguer, S. B. Horwitz, L. Wilson, C. Briand, and M. A. Jordan
Synergistic Suppression of Microtubule Dynamics by Discodermolide and Paclitaxel in Non-Small Cell Lung Carcinoma Cells
Cancer Res., July 15, 2004; 64(14): 4957 - 4964.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Goodin, M. P. Kane, and E. H. Rubin
Epothilones: Mechanism of Action and Biologic Activity
J. Clin. Oncol., May 15, 2004; 22(10): 2015 - 2025.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M. A. Jordan
Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation
Mol. Cancer Ther., December 1, 2003; 2(12): 1303 - 1311.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.